CDKN2A and hepatocellular carcinoma: In support of this view, one study reported that inhibition of SIRT6 expression could promote the expressions of p21 and p16 through its regulation of ERK pathway, thereby inducing cellular senescence and reducing the tumorigenicity of hepatoma cells (50).